Ribbon-Cutting Ceremony Marks Commitment to Animal Identification Products
Increased Local Investment Builds Strength for the Future to Better Meet Customer Demand
GURUGRAM, INDIA, November 6, 2019 – Allflex Livestock Intelligence today announced the dedication of a new manufacturing, packaging and warehousing facility in Gurugram, India, for the manufacture of animal identification visual ear tags for India and export to other countries in the Asia Pacific Region. The company’s animal identification business develops and markets visual ear tags (VID) that contain printed identification numbers unique to the animal or the farm, helping dairy farmers and producers track animal traceability and proof of ownership as well as comply with government regulations. The fully operational site has received a factory license from the Directorate of Industrial Safety & Health, Labour Department in Haryana, Chandigarth, which will allow the company to continue its manufacturing operations.
“We are delighted and honored to inaugurate this new facility in Gurugram, as we begin an exciting new stage of our business journey towards extending the range of leading technology, experience and services for our customers in India,” said Lokesh Kothari, Commercial Leader, Allflex Livestock Intelligence in India. “We have been in the Indian market for 10 years and continually look to create new ways and processes to better serve our customers. We also are strengthening our local investment in building our manufacturing and warehousing capacity and capabilities so that we remain a valued partner to our local customers through our reliability, flexibility and responsiveness. This new facility positions our company for strong long-term growth.”
“The investment in our India facility is another example of our contribution to and expansion of our footprint in the Asia Pacific Region, to help advance our mission of connecting animal and people,” said Jeroen van de Ven, Chief Operating Officer, Allflex Livestock Intelligence. “We are working closely with the Indian Government’s Information Network on Animal Production and Health (INAPH) to lend our expertise in managing hundreds of millions of dairy cows in the country to safeguard animal health and well-being, while achieving optimal health treatment and interventions.”
“The factory license from the Directorate of Industrial Safety & Health, Labour Department in Haryana, Chandigarth, has great symbolic significance for Allflex Livestock Intelligence and our India manufacturing facility. Receiving this designation from the Government of India underscores our ongoing dedication to ensure that our products will be of exceptional quality and our continued commitment to meet and exceed the industry’s highest safety standards,” said Kothari.
“As a leader in delivering innovative pharmaceuticals and vaccines to advance animal health and meet growing customer needs, this investment in people, technology and equipment reflects our commitment to produce a range of veterinary pharmaceuticals, vaccines and health management solutions and services as well as an extensive suite of digitally connected identification, trace-ability and monitoring products,” said Rick DeLuca, President, MSD Animal Health.
“Creating enhanced methods and processes to better serve our customers are one part of our multi-faceted approach,” said Jean-Jacques Hilpert, Leader, Global Manufacturing and Supply Chain, Allflex Livestock Intelligence. “We continue to explore ways around the world to enhance existing facilities with upgraded equipment or technology, further expand our facilities with advanced technology platforms, and increase capacity and capabilities in manufacturing, packaging and warehousing to meet the rapidly growing demand for our products.”
About Allflex Livestock Intelligence
Allflex Livestock Intelligence is a world leader in the design, development, manufacturing and delivery of solutions for animal identification, monitoring and traceability. Our data-driven solutions are used by farmers, companies and countries to manage hundreds of millions of animals worldwide. By putting intelligent, actionable management information into farmers’ hands, our solutions empower them to act in a timely manner to safeguard their animals’ health and well-being, while achieving optimal production outcomes for a healthy food supply. Allflex Livestock Intelligence is a Livestock portfolio of digital products within MSD Animal Health.
As the largest provider of animal identification technology, we meet growing customer needs by providing over 500 million tags for identifying, tracking and monitoring animals every year and we monitor over 5.5 million cows daily, which allows access to real-time, actionable data and insights to help improve or enhance animal management and health outcomes.
With over 60 years of experience and around 1,900 team members worldwide, we have a global network of experts, each with a great depth of experience and unparalleled knowledge, who provide a valuable resource to farmers, companies and countries. Allflex Livestock Intelligence has manufacturing and technology subsidiaries in North America, Europe, Israel, South America, China, Australia and New Zealand. Our products are distributed in over 100 countries.
Through its commitment to The Science of Healthier Animals®, MSD Animal Health offers veterinarians, farmers, pet owners and governments one of the widest ranges of veterinary pharmaceuticals, vaccines and health management solutions and services as well as an extensive suite of digitally connected identification, traceability and monitoring products. Merck Animal Health is dedicated to preserving and improving the health, well-being and performance of animals and the people who care for them.
For more information, visit https://www.allflex.global.
Forward-Looking Statement of Merck & Co., Inc., Kenilworth, N.J., USA
This news release of Merck & Co., Inc., Kenilworth, N.J., USA (the “company”) includes “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements are based upon the current beliefs and expectations of the company’s management and are subject to significant risks and uncertainties. There can be no guarantees with respect to pipeline products that the products will receive the necessary regulatory approvals or that they will prove to be commercially successful. If underlying assumptions prove inaccurate or risks or uncertainties materialize, actual results may differ materially from those set forth in the forward-looking statements.
Risks and uncertainties include but are not limited to, general industry conditions and competition; general economic factors, including interest rate and currency exchange rate fluctuations; the impact of pharmaceutical industry regulation and health care legislation in the United States and internationally; global trends toward health care cost containment; technological advances, new products and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approval; the company’s ability to accurately predict future market conditions; manufacturing difficulties or delays; financial instability of international economies and sovereign risk; dependence on the effectiveness of the company’s patents and other protections for innovative products; and the exposure to litigation, including patent litigation, and/or regulatory actions.
The company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Additional factors that could cause results to differ materially from those described in the forward-looking statements can be found in the company’s 2018 Annual Report on Form 10-K and the company’s other filings with the Securities and Exchange Commission (SEC) available at the SEC’s Internet site (www.sec.gov).